Astellas Pharma Inc
(OTC:ALPMY)
Astellas Pharma Inc is a specialty global pharmaceutical company. The company focuses on accelerating the discovery, development and commercialization of ground-breaking innovations that could redefine expectations of care for difficult-to-treat diseases. The group is committed to driving innovation in immuno-oncology, gene therapy, mitochondria, blindness and regeneration, and targeted protein degradation. The company operates its business in approximately 70 countries around the world. Its core products include anticancer agents like XTANDI, XOSPATA, and PADCEV; VEOZAH for the treatment of vasomotor symptoms due to menopause; Betanis / Myrbetriq / BETMIGA for the treatment of overactive bladder (OAB); and Prograf, an immunosuppressant for organ transplantation.
top performing ALPMY trades
-21.60%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Astellas Pharma trades made by congress members.
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Purchase | Mar 20, 2023 | Feb 27, 2023 | House |
Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Sale | Feb 24, 2023 | Jan 13, 2023 | House |